Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BXT-51072 for Cardioprotection in Type 2 Diabetics Undergoing PCI
NCT00320502Phase 2Completed
- Sponsor
- Synvista Therapeutics, Inc.
- Start
- May 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alt-2074 in acute coronary syndrome (ACS), myocardial infarction (MI), sponsored by Synvista Therapeutics, Inc.. Started May 2006; status: completed.
02
Drugs
alt-2074
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00320502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320502.